{
  "id": 8203591,
  "title": "How China plans to ‘firmly rank at the global forefront’ with 25% of first-in-class drugs",
  "url": "https://urgent.news/2026/09/18/how-china-plans-to-firmly-rank-at-the-global-forefront-with-25-of",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-09-18T08:00:06.000Z",
  "source": {
    "name": "SCMP Business",
    "slug": "scmp-business",
    "url": "https://www.scmp.com/business/china-business/article/3367952/how-china-plans-firmly-rank-global-forefront-25-first-class-drugs"
  },
  "original_language": "en",
  "account": "China has unveiled an ambitious five-year plan aimed at solidifying its position as a global leader in biomedicine by 2030. The government's strategy outlines critical milestones, targeting at least 25 percent of the world's first-in-class drugs market and promoting the biomedical industry as a \"pillar industry\" for the nation. By the end of the decade, China aims to \"firmly rank at the global forefront\" in biopharmaceutical research and development, with core competitiveness and international influence significantly enhanced. The plan, jointly published by eight government agencies, sets 10 measurable targets, including pharmaceutical enterprises generating combined revenue of no less than 3.5 trillion yuan and the country producing drug makers with annual revenue exceeding 10 billion yuan. The biomedical industry is projected to grow at an annual rate of more than 20 percent by 2030, with a substantial number of cutting-edge innovations emerging from Chinese-developed first-in-class drugs.",
  "summary": "China has set its sights on becoming a global biomedicine powerhouse by 2030, targeting key technological breakthroughs and at least a quarter of the world’s first-in-class drugs market under a new five-year plan for the sector. By the end of the decade, China would “firmly rank at the global forefront” in biopharmaceutical research and development and applications, with its “core…",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 4,
    "also_reported_by": [
      {
        "outlet": "Investing.com",
        "title": "China set to keep loan rates steady for 16th consecutive month in September",
        "url": "https://urgent.news/2026/09/18/china-set-to-keep-loan-rates-steady-for-16th-consecutive-month-in",
        "published": "2026-09-18T06:36:28.000Z"
      },
      {
        "outlet": "SCMP Business",
        "title": "From US Fed rates to China’s global export share: 4 figures shaping markets",
        "url": "https://urgent.news/2026/09/18/from-us-fed-rates-to-chinas-global-export-share-4-figures-shaping",
        "published": "2026-09-18T07:00:23.000Z"
      },
      {
        "outlet": "Seeking Alpha News",
        "title": "China’s CXMT eyes flash-memory push amid global shortage - report",
        "url": "https://urgent.news/2026/09/18/chinas-cxmt-eyes-flash-memory-push-amid-global-shortage-report",
        "published": "2026-09-18T07:24:41.000Z"
      }
    ]
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}